APA (7th ed.) Citation

Pison, C., Shah, P. L., Slebos, D., Ninane, V., Janssens, W., Perez, T., . . . Valipour, A. (2021). Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes. Respiratory Research, 22(1), 1. https://doi.org/10.1186/s12931-021-01664-5

Chicago Style (17th ed.) Citation

Pison, Christophe, et al. "Safety of Denervation Following Targeted Lung Denervation Therapy for COPD: AIRFLOW-1 3-year Outcomes." Respiratory Research 22, no. 1 (2021): 1. https://doi.org/10.1186/s12931-021-01664-5.

MLA (9th ed.) Citation

Pison, Christophe, et al. "Safety of Denervation Following Targeted Lung Denervation Therapy for COPD: AIRFLOW-1 3-year Outcomes." Respiratory Research, vol. 22, no. 1, 2021, p. 1, https://doi.org/10.1186/s12931-021-01664-5.